Evaluation of bird-adapted self-amplifying mRNA vaccine formulations in chickens
Open Access
- 23 March 2024
- Vol. 42 (11) , 2895-2908
Abstract
No abstract availableKeywords
Funding Information
- MSD Animal Health
This publication has 60 references indexed in Scilit:
- Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjectsEuropean Journal of Immunology, 2022
- Impact of lipid nanoparticle size on mRNA vaccine immunogenicityJournal of Controlled Release, 2021
- Vaccination of poultry successfully eliminated human infection with H7N9 virus in ChinaScience China Life Sciences, 2018
- Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in ChinaBiologicals, 2010
- Alphavirus replicon particle vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: Proof of conceptVaccine, 2010
- Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primatesVaccine, 2009
- Epidemiology of H5N1 avian influenzaComparative Immunology, Microbiology and Infectious Diseases, 2009
- Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infectionVaccine, 2007
- Influenza Virus (A/HK/156/97) Hemagglutinin Expressed by an Alphavirus Replicon System Protects Chickens against Lethal Infection with Hong Kong-Origin H5N1 VirusesVirology, 2000
- Noncytopathic Flavivirus Replicon RNA-Based System for Expression and Delivery of Heterologous GenesVirology, 1999